Treatment of active SLE-associated glomerulonephritis (GN) with the innovative immunosuppressant 15-deoxyspergualin (DSG; Gusperimus) - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Treatment of active SLE-associated glomerulonephritis (GN) with the innovative immunosuppressant 15-deoxyspergualin (DSG; Gusperimus)

Authors list: Lorenz, H. M.; Schmitt, W. A.; Mueller-Ladner, U.; Hauser, I. A.; Hiepe, F.; Tesar, V; Woehling, H.; Heinzel, P. A.

Publication year: 2007

Pages: 20-20

Journal: Zeitschrift für Rheumatologie

Volume number: 66

ISSN: 0340-1855

eISSN: 1435-1250

Publisher: Springer

Citation Styles

Harvard Citation style: Lorenz, H., Schmitt, W., Mueller-Ladner, U., Hauser, I., Hiepe, F., Tesar, V., et al. (2007) Treatment of active SLE-associated glomerulonephritis (GN) with the innovative immunosuppressant 15-deoxyspergualin (DSG; Gusperimus), Zeitschrift für Rheumatologie, 66, p. 20

APA Citation style: Lorenz, H., Schmitt, W., Mueller-Ladner, U., Hauser, I., Hiepe, F., Tesar, V., Woehling, H., & Heinzel, P. (2007). Treatment of active SLE-associated glomerulonephritis (GN) with the innovative immunosuppressant 15-deoxyspergualin (DSG; Gusperimus). Zeitschrift für Rheumatologie. 66, 20.